DE60122750D1 - Amidine-inhibitoren der serine-proteasen - Google Patents

Amidine-inhibitoren der serine-proteasen

Info

Publication number
DE60122750D1
DE60122750D1 DE60122750T DE60122750T DE60122750D1 DE 60122750 D1 DE60122750 D1 DE 60122750D1 DE 60122750 T DE60122750 T DE 60122750T DE 60122750 T DE60122750 T DE 60122750T DE 60122750 D1 DE60122750 D1 DE 60122750D1
Authority
DE
Germany
Prior art keywords
serine proteases
inhibitors
factor
amidine
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60122750T
Other languages
English (en)
Other versions
DE60122750T2 (de
Inventor
M Pastor
R Artis
G Olivera
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of DE60122750D1 publication Critical patent/DE60122750D1/de
Publication of DE60122750T2 publication Critical patent/DE60122750T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • C07D207/48—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Detergent Compositions (AREA)
  • Treating Waste Gases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
DE60122750T 2000-09-11 2001-09-05 Amidin-Inhibitoren von Serin-Proteasen Expired - Lifetime DE60122750T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23167900P 2000-09-11 2000-09-11
US231679P 2000-09-11
PCT/US2001/027640 WO2002022575A1 (en) 2000-09-11 2001-09-05 Amidine inhibitors of serine proteases

Publications (2)

Publication Number Publication Date
DE60122750D1 true DE60122750D1 (de) 2006-10-12
DE60122750T2 DE60122750T2 (de) 2006-12-21

Family

ID=22870229

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60122750T Expired - Lifetime DE60122750T2 (de) 2000-09-11 2001-09-05 Amidin-Inhibitoren von Serin-Proteasen

Country Status (8)

Country Link
US (2) US6410733B1 (de)
EP (1) EP1317429B1 (de)
JP (1) JP2004509104A (de)
AT (1) ATE338030T1 (de)
AU (1) AU2001288819A1 (de)
CA (1) CA2421548C (de)
DE (1) DE60122750T2 (de)
WO (1) WO2002022575A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6291514B1 (en) * 1998-02-09 2001-09-18 3-Dimensional Pharmaceuticals, Inc. Heteroaryl amidines, methylamidines and guanidines, preparation thereof, and use thereof as protease inhibitors
AU2001288819A1 (en) * 2000-09-11 2002-03-26 Genentech, Inc. Amidine inhibitors of serine proteases
EP1432687A2 (de) * 2001-10-03 2004-06-30 Pharmacia Corporation Substitutierte fünfgliedrige polyzyclischen vebindungen für die selektive hemmung der koagulationskaskade
WO2003037326A1 (en) * 2001-10-29 2003-05-08 Corvas International, Inc. Solid phase synthesis of chemical libraries
JP2005538953A (ja) * 2002-05-28 2005-12-22 ３−ディメンショナル ファーマシューティカルズ， インコーポレイテッド 新規チオフェンアミジン、それらの組成物、および補体媒介疾患および病気を治療する方法
US7659305B2 (en) 2002-10-31 2010-02-09 Pfizer Inc. Therapeutic proline derivatives
DK1569912T3 (en) 2002-12-03 2015-06-29 Pharmacyclics Inc 2- (2-hydroxybiphenyl-3-yl) -1h-benzoimidazole-5-carboxamidine derivatives as factor VIIa inhibitors.
JP4705015B2 (ja) 2003-04-03 2011-06-22 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング カルボニル化合物
US7273886B2 (en) 2003-05-20 2007-09-25 Genentech, Inc. Benzofuran inhibitors of factor VIIa
JP4947406B2 (ja) * 2003-08-29 2012-06-06 小野薬品工業株式会社 Ｓ１ｐ受容体結合能を有する化合物およびその医薬用途
US7550487B2 (en) 2004-03-26 2009-06-23 Hoffmann-La Roche Inc. Pyrrolidine-3,4-dicarboxamide derivatives
ATE533491T1 (de) * 2004-09-21 2011-12-15 Trobio Ab Stabilisierte protease zusammensetzungen enthaltend eine serinprotease, morpholin-derivate und reversible serinprotease- inhibitoren
WO2006073167A1 (ja) * 2005-01-07 2006-07-13 Ono Pharmaceutical Co., Ltd. ピロリジン誘導体
CN102380100A (zh) * 2005-09-22 2012-03-21 特罗比奥股份公司 稳定的蛋白酶组合物
CA2621059C (en) * 2005-09-22 2013-08-13 Trobio Ab Stabilized protease composition
WO2007057317A1 (en) * 2005-11-16 2007-05-24 F. Hoffmann-La Roche Ag Novel pyrrolidine derivatives as inhibitors of coagulation factor xa
US8889117B2 (en) * 2007-02-15 2014-11-18 Yale University Modular nanoparticles for adaptable vaccines
US8236792B2 (en) * 2008-05-23 2012-08-07 Janssen Pharmaceutica Nv Substituted pyrrolidine amides as modulators of the histamine H3 receptor
EP2520566A1 (de) * 2011-05-06 2012-11-07 Orion Corporation Neue pharmazeutische Verbindungen
WO2015009473A1 (en) 2013-07-17 2015-01-22 Exxonmobil Chemical Patents Inc. Cyclopropyl substituted metallocene catalysts
WO2015009470A1 (en) 2013-07-17 2015-01-22 Exxonmobil Chemical Patents Inc. Metallocenes and catalyst compositions derived therefrom
WO2015009472A1 (en) 2013-07-17 2015-01-22 Exxonmobil Chemcal Patents Inc. Metallocenes and catalyst compositions derived therefrom
CN103396351B (zh) * 2013-08-09 2015-10-21 山东大学 吡咯烷类Bcl-2蛋白小分子抑制剂化合物及其制备、药物组合物与制药用途
CN105899487B (zh) * 2013-12-27 2018-10-19 株式会社Api 5-羟基哌啶-2-甲酸的制造方法
CN109312013A (zh) 2016-05-27 2019-02-05 埃克森美孚化学专利公司 茂金属催化剂组合物和使用其的聚合方法
US11472828B2 (en) 2019-10-11 2022-10-18 Exxonmobil Chemical Patents Inc. Indacene based metallocene catalysts useful in the production of propylene polymers
WO2021211913A1 (en) * 2020-04-17 2021-10-21 Baylor College Of Medicine Direct thrombin inhibitors and methods of use thereof

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5589173A (en) 1986-11-04 1996-12-31 Genentech, Inc. Method and therapeutic compositions for the treatment of myocardial infarction
US5580560A (en) 1989-11-13 1996-12-03 Novo Nordisk A/S Modified factor VII/VIIa
US5504064A (en) 1991-04-10 1996-04-02 Oklahoma Medical Research Foundation Treatment of bleeding with modified tissue factor in combination with an activator of FVII
US5374617A (en) 1992-05-13 1994-12-20 Oklahoma Medical Research Foundation Treatment of bleeding with modified tissue factor in combination with FVIIa
WO1993009804A1 (en) 1991-11-18 1993-05-27 The Scripps Research Institute Serine protease derived-polypeptides and anti-peptide antibodies, systems and therapeutic methods for inhibiting coagulation
JP3194953B2 (ja) 1992-02-14 2001-08-06 コルバス・インターナショナル、インコーポレイテッド 血栓症抑制剤
CA2151044A1 (en) 1992-12-15 1994-06-23 Terence K. Brunck Novel inhibitors for factor xa
US5656600A (en) 1993-03-25 1997-08-12 Corvas International, Inc. α-ketoamide derivatives as inhibitors of thrombosis
US5726159A (en) 1994-03-04 1998-03-10 Eli Lilly And Company Antithrombotic agents
US5681844A (en) 1994-04-18 1997-10-28 Corvas International, Inc. Methionine sulfone and s-substituted cysteine sulfone derivatives as enzyme inhibitors
IL115420A0 (en) 1994-09-26 1995-12-31 Zeneca Ltd Aminoheterocyclic derivatives
US5998379A (en) * 1994-11-21 1999-12-07 Cortech Inc. Serine protease inhibitors-proline analogs
US5869501A (en) 1994-12-02 1999-02-09 Yamanouchi Pharmaceutical Co. Ltd Amidinonaphthyl derivative or salt thereof
US5656645A (en) 1994-12-13 1997-08-12 Corvas International, Inc. Aromatic heterocyclic derivatives as enzyme inhibitors
US5658930A (en) 1994-12-13 1997-08-19 Corvas International, Inc. Aromatic heterocyclic derivatives as enzyme inhibitors
US5612353A (en) 1995-06-07 1997-03-18 Rhone-Poulenc Rorer Pharmaceuticals Inc. Substituted (sulfinic acid, sulfonic acid, sulfonylamino or sulfinylamino) N-[(aminoiminomethyl)phenylalkyl]-azaheterocyclylamide compounds
WO1997030073A1 (en) 1996-02-13 1997-08-21 Akzo Nobel N.V. Serine protease inhibitors
US6057342A (en) 1996-08-16 2000-05-02 Dupont Pharmaceutical Co. Amidinophenyl-pyrrolidines, -pyrrolines, and -isoxazolidines and derivatives thereof
US6291514B1 (en) * 1998-02-09 2001-09-18 3-Dimensional Pharmaceuticals, Inc. Heteroaryl amidines, methylamidines and guanidines, preparation thereof, and use thereof as protease inhibitors
WO1999064392A1 (fr) 1998-06-08 1999-12-16 Ajinomoto Co., Inc. Derive de benzamidine
AU2001288819A1 (en) * 2000-09-11 2002-03-26 Genentech, Inc. Amidine inhibitors of serine proteases

Also Published As

Publication number Publication date
US20020055469A1 (en) 2002-05-09
EP1317429A1 (de) 2003-06-11
DE60122750T2 (de) 2006-12-21
WO2002022575A1 (en) 2002-03-21
US6410733B1 (en) 2002-06-25
ATE338030T1 (de) 2006-09-15
CA2421548C (en) 2007-10-30
AU2001288819A1 (en) 2002-03-26
CA2421548A1 (en) 2002-03-21
EP1317429B1 (de) 2006-08-30
JP2004509104A (ja) 2004-03-25
US20030229133A1 (en) 2003-12-11
US6838479B2 (en) 2005-01-04

Similar Documents

Publication Publication Date Title
ATE338030T1 (de) Amidine-inhibitoren der serine-proteasen
MXPA03009130A (es) Compuestos de biarilo que funcionan como inhibidores de proteasa serina.
ATE307111T1 (de) Serinprotease-inhibitoren
ATE268766T1 (de) Stickstoff enthaltende heterobicyclen als factor xa inhibitoren
TR200402535T4 (tr) Serin proteaz inhibitörleri.
DK1086122T3 (da) Pyrazinonproteaseinhibitorer
TR200002904T2 (tr) Amidin bileşikleri
WO1996035788A3 (en) Kunitz type protease inhibitors
TR199801569T2 (xx) Serin proteaz inhibit�rleri.
TW200745062A (en) Macrocyclic factor VIIA inhibitors useful as anticoagulants
DE69902754T2 (de) Heteroaryl-amidinen,-methylamidinen und -guanidinen als protease inhibitoren, insbesondere als urokinase inhibitoren
DE60105418D1 (de) Serinprotease-inhibitoren
DE69818510D1 (de) Neue verbindungen
DE60113252D1 (de) Inhibitoren von serin proteasen
MXPA01008084A (es) Heteroarilamidinas, metilamidinas y guanidinas como inhibidores de proteasa.
WO1999063090A3 (en) Protease inhibitor peptides
ATE250056T1 (de) Heteroaryl protease inhibitoren und diagnostische bilderzeugungsmittel
ATE407116T1 (de) Neue amidino-derivate und deren verwendung als thrombin-inhibitoren
MXPA03000963A (es) Inhibidores de oxiguanidina ciclica proteasa.
TR200102914T2 (tr) Trombin önleyicilerinin önilaçları
IS7162A (is) Nýjar möndlusýruafleiður og notkun þeirra sem þrombínhemla
PT1075476E (pt) Novos benzimidazoles e benzoxazoles

Legal Events

Date Code Title Description
8364 No opposition during term of opposition